XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Mar. 31, 2023 6,271,971      
Balance at Mar. 31, 2023 $ 125 $ 33,856 $ (17,634) $ 16,347
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 12,821      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 1 10 0 11
Share-based compensation expense 0 139 0 139
Net income (loss) $ 0 0 (3,186) (3,186)
Proceeds from the sale of common stock, net of expenses (in shares) 400,000      
Proceeds from the sale of common stock, net of expenses $ 8 384 0 392
Net loss $ 0 0 (3,186) (3,186)
Issuances of common stock for Directors Stock Grants (in shares) 159,493      
Issuances of common stock for Directors Stock Grants $ 3 123 0 126
Issuances of common stock to Directors in lieu of cash for prior year board fees (in shares) 17,672      
Issuances of common stock to Directors in lieu of cash for prior year board fees $ 0 15 0 15
Issuances of vested shares of restricted stock (in shares) 37,996      
Issuances of vested shares of restricted stock $ 1 (12) 0 (11)
Shares withheld for tax payments (in shares) (13,353)      
Shares withheld for tax payments $ 0 0 0 0
Balance (in shares) at Dec. 31, 2023 6,886,600      
Balance at Dec. 31, 2023 $ 138 34,515 (20,820) 13,833
Balance (in shares) at Sep. 30, 2023 6,473,779      
Balance at Sep. 30, 2023 $ 129 34,078 (19,800) 14,407
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 12,821      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 1 10 0 11
Share-based compensation expense 0 43 0 43
Net income (loss) $ 0 0 (1,020) (1,020)
Proceeds from the sale of common stock, net of expenses (in shares) 400,000      
Proceeds from the sale of common stock, net of expenses $ 8 384 0 392
Net loss $ 0 0 (1,020) (1,020)
Balance (in shares) at Dec. 31, 2023 6,886,600      
Balance at Dec. 31, 2023 $ 138 34,515 (20,820) 13,833
Balance (in shares) at Mar. 31, 2024 6,947,246      
Balance at Mar. 31, 2024 $ 139 34,576 (22,901) 11,814
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 26,492      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 1 19 0 20
Share-based compensation expense 0 113 0 113
Net income (loss) 0 0 (2,576) (2,576)
Net loss $ 0 0 (2,576) (2,576)
Issuances of common stock for Directors Stock Grants (in shares) 116,049      
Issuances of common stock for Directors Stock Grants $ 2 92 0 94
Issuances of common stock to Directors in lieu of cash for prior year board fees (in shares) 53,333      
Issuances of common stock to Directors in lieu of cash for prior year board fees $ 1 39 40
Issuances of vested shares of restricted stock (in shares) 20,456      
Issuances of vested shares of restricted stock $ 0 (5) 0 (5)
Shares withheld for tax payments (in shares) (7,718)      
Shares withheld for tax payments $ 0 0 0 0
Balance (in shares) at Dec. 31, 2024 7,155,858      
Balance at Dec. 31, 2024 $ 143 34,834 (25,477) 9,500
Balance (in shares) at Sep. 30, 2024 7,142,700      
Balance at Sep. 30, 2024 $ 143 34,802 (25,253) 9,692
Issuances of common stock to Directors in lieu of cash for current year board fees (in shares) 13,158      
Issuances of common stock to Directors in lieu of cash for current year board fees $ 0 10 0 10
Share-based compensation expense 0 22 0 22
Net income (loss) 0 0 (224) (224)
Net loss $ 0 0 (224) (224)
Balance (in shares) at Dec. 31, 2024 7,155,858      
Balance at Dec. 31, 2024 $ 143 $ 34,834 $ (25,477) $ 9,500